"FenoLogica Biosciences CEO Sean MacLeod sees promise in a business model that uses cloud computing and high-tech hardware to accelerate laborious by-hand research."
Yeast – the single-celled organism crucial for brewing beer, baking bread, and making wine – is also a powerful test-bed for studying cell biology and disease. It has long been one of the best-studied model organisms for basic biological research because many essential cellular processes are the same in yeast and humans.
Yeast is one of most thoroughly researched model organisms in modern cell biology – as evidenced by the 6+ Nobel Laureates awarded for their breakthrough discoveries in yeast towards cell function and cancer since 2001.
FenoLogica Biosciences, a Seattle-based biotechnology firm, is pleased to announce five new pilot customers for its' Cloud-based cell analytics platform. The company has secured collaboration agreements with research entities in Toronto, Silicon Valley, Wisconsin, San Diego and Vancouver, BC.
Seattle, WA - September 19, 2016 - FenoLogica Biosciences Inc., a Seattle-WA-based life sciences company, announces completion of a licensing and collaboration agreement with the Pacific Northwest Research Institute (PNRI). FenoLogica also announces closing of its seed investment round that took place on June 13, 2016.